Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Beltran Lab
Explore this Website
Home
About Us
Toggle About Us menu options
Contact Us
Job Opportunities
Videos
Affiliations
Research
Lab Team
News
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Affiliations
Research
Lab Team
News
Publications
Home
Publications
Publications
Found 69 results
Author
Title
Type
Year
Filters:
About-us
is
contact-us
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
W
Wilkes DC
,
Sailer V
,
Xue H
,
Cheng H
,
Collins CC
,
Gleave M
,
Wang Y
,
Demichelis F
,
Beltran H
,
Rubin MA
et al.
. 2017.
A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agents.
.
Cold Spring Harb Mol Case Stud. 3(5)
T
Terry S
,
Maillé P
,
Baaddi H
,
Kheuang L
,
Soyeux P
,
Nicolaiew N
,
Ceraline J
,
Firlej V
,
Beltran H
,
Allory Y
et al.
. 2013.
Cross modulation between the androgen receptor axis and protocadherin-PC in mediating neuroendocrine transdifferentiation and therapeutic resistance of prostate cancer.
.
Neoplasia. 15(7):761-72.
Terry S
,
Beltran H
. 2014.
The many faces of neuroendocrine differentiation in prostate cancer progression.
.
Front Oncol. 4:60.
Terry S
,
El-Sayed IY
,
Destouches D
,
Maillé P
,
Nicolaiew N
,
Ploussard G
,
Semprez F
,
Pimpie C
,
Beltran H
,
Londono-Vallejo A
et al.
. 2015.
CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities.
.
Oncotarget. 6(14):11994-2008.
Tagawa ST
,
Beltran H
. 2011.
Abiraterone plus prednisone improves survival in metastatic castration-resistant prostate cancer.
.
Asian J Androl. 13(6):785-6.
S
Sternberg CN
,
Beltran H
. 2017.
Prostate cancer in 2016: Improved outcomes and precision medicine come within reach.
.
Nat Rev Urol. 14(2):71-72.
Shukla S
,
Cyrta J
,
Murphy DA
,
Walczak EG
,
Ran L
,
Agrawal P
,
Xie Y
,
Chen Y
,
Wang S
,
Zhan Y
et al.
. 2017.
Aberrant Activation of a Gastrointestinal Transcriptional Circuit in Prostate Cancer Mediates Castration Resistance.
.
Cancer Cell. 32(6):792-806.e7.
Sailer V
,
Pauli C
,
Merzier EC
,
Mosquera JMiguel
,
Beltran H
,
Rubin MA
,
Rao RA
. 2017.
On-site Cytology for Development of Patient-Derived Three-dimensional Organoid Cultures - A Pilot Study.
.
Anticancer Res. 37(4):1569-1573.
Sailer V
,
Schiffman MH
,
Kossai M
,
Cyrta J
,
Beg S
,
Sullivan B
,
Pua BB
,
Lee KSteve
,
Talenfeld AD
,
Nanus DM
et al.
. 2017.
Bone biopsy protocol for advanced prostate cancer in the era of precision medicine.
.
Cancer.
R
Robinson D
,
Van Allen EM
,
Wu Y-M
,
Schultz N
,
Lonigro RJ
,
Mosquera J-M
,
Montgomery B
,
Taplin M-E
,
Pritchard CC
,
Attard G
et al.
. 2015.
Integrative clinical genomics of advanced prostate cancer.
.
Cell. 161(5):1215-28.
Rickman DS
,
Beltran H
,
Demichelis F
,
Rubin MA
. 2017.
Biology and evolution of poorly differentiated neuroendocrine tumors.
.
Nat Med. 23(6):1-10.
Ramnarine VRohan
,
Alshalalfa M
,
Mo F
,
Nabavi N
,
Erho N
,
Takhar M
,
Shukin R
,
Brahmbhatt S
,
Gawronski A
,
Kobelev M
et al.
. 2018.
The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.
.
Gigascience.
P
Puca L
,
Vlachostergios PJ
,
Beltran H
. 2018.
Neuroendocrine Differentiation in Prostate Cancer: Emerging Biology, Models, and Therapies.
.
Cold Spring Harb Perspect Med.
Puca L
,
Bareja R
,
Prandi D
,
Shaw R
,
Benelli M
,
Karthaus WR
,
Hess J
,
Sigouros M
,
Donoghue A
,
Kossai M
et al.
. 2018.
Patient derived organoids to model rare prostate cancer phenotypes.
.
Nat Commun. 9(1):2404.
Pritchard CC
,
Mateo J
,
Walsh MF
,
De Sarkar N
,
Abida W
,
Beltran H
,
Garofalo A
,
Gulati R
,
Carreira S
,
Eeles R
et al.
. 2016.
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
.
N Engl J Med. 375(5):443-53.
Prandi D
,
Baca SC
,
Romanel A
,
Barbieri CE
,
Mosquera J-M
,
Fontugne J
,
Beltran H
,
Sboner A
,
Garraway LA
,
Rubin MA
et al.
. 2014.
Unraveling the clonal hierarchy of somatic genomic aberrations.
.
Genome Biol. 15(8):439.
Pisapia DJ
,
Salvatore S
,
Pauli C
,
Hissong E
,
Eng K
,
Prandi D
,
Sailer V-W
,
Robinson BD
,
Park K
,
Cyrta J
et al.
. 2017.
Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical Models.
.
JCO Precis Oncol. 2017
Pauli C
,
Puca L
,
Mosquera JMiguel
,
Robinson BD
,
Beltran H
,
Rubin MA
,
Rao RA
. 2016.
An emerging role for cytopathology in precision oncology.
.
Cancer Cytopathol. 124(3):167-73.
Pauli C
,
Hopkins BD
,
Prandi D
,
Shaw R
,
Fedrizzi T
,
Sboner A
,
Sailer V
,
Augello M
,
Puca L
,
Rosati R
et al.
. 2017.
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.
.
Cancer Discov.
Park K
,
Chen Z
,
MacDonald TY
,
Siddiqui J
,
Ye H
,
Erbersdobler A
,
Shevchuk MM
,
Robinson BD
,
Sanda MG
,
Chinnaiyan AM
et al.
. 2014.
Prostate cancer with Paneth cell-like neuroendocrine differentiation has recognizable histomorphology and harbors AURKA gene amplification.
.
Hum Pathol. 45(10):2136-43.
O
O'Rourke KP
,
Loizou E
,
Livshits G
,
Schatoff EM
,
Baslan T
,
Manchado E
,
Simon J
,
Romesser PB
,
Leach B
,
Han T
et al.
. 2017.
Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer.
.
Nat Biotechnol. 35(6):577-582.
M
Mu P
,
Zhang Z
,
Benelli M
,
Karthaus WR
,
Hoover E
,
Chen C-C
,
Wongvipat J
,
Ku S-Y
,
Gao D
,
Cao Z
et al.
. 2017.
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer.
.
Science. 355(6320):84-88.
Mosquera JM
,
Beltran H
,
Park K
,
MacDonald TY
,
Robinson BD
,
Tagawa ST
,
Perner S
,
Bismar TA
,
Erbersdobler A
,
Dhir R
et al.
. 2013.
Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer.
.
Neoplasia . (1):1-10.
Mateo J
,
Cheng HH
,
Beltran H
,
Dolling D
,
Xu W
,
Pritchard CC
,
Mossop H
,
Rescigno P
,
Perez-Lopez R
,
Sailer V
et al.
. 2018.
Clinical Outcome of Prostate Cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International Study.
.
Eur Urol.
L
Lin PC
,
Giannopoulou EG
,
Park K
,
Mosquera JM
,
Sboner A
,
Tewari AK
,
Garraway LA
,
Beltran H
,
Rubin MA
,
Elemento O
. 2013.
Epigenomic alterations in localized and advanced prostate cancer.
.
Neoplasia. 15(4):373-83.
1
(current)
2
3
next ›
last »